Skip to content
#diffusion models Open access

Deep learning radiomics based on preoperative multiparametric MRI in predicting breast cancer recurrence risk

Sep 2026 · BMC Medical Imaging · Vol 26 · 0 citations · 38 references
Medicine Computer Science

TL;DR

The DLRC model effectively predicted and stratified breast cancer recurrence risk by integrating deep learning, radiomics, and clinicopathological features and achieved the best performance in the training and internal validation sets.

Abstract

Breast cancer treatments are often tailored to recurrence risk to improve outcomes, but reliable risk stratification methods are lacking. To predict preoperative breast cancer recurrence risk through a tridimensional synergy model integrating breast MRI, radiomics, and deep learning. Retrospective. 428 female patients were randomly divided into training (n = 299, 52.5 ± 12.2 years) and internal validation (n = 129, 53.2 ± 11.5 years) sets, with an external validation set of 196 patients (51.3 ± 11.2 years). Multiparametric 3T MRI included fat-suppressed T2-weighted (T2WI) spin-echo, axial diffusion-weighted imaging (DWI), and dynamic contrast-enhanced MRI (DCE-MRI) with one pre- and five post-contrast axial acquisitions. We compared recurrence-free survival (RFS) prediction among DLR, DLC, and DLRC models, selected the optimal DLRC to stratify patients by risk, assessed RFS differences, and validated predictions, confirming effective risk stratification. Continuous corrected chi-squared tests, one-way ANOVA, log-rank test. A two-tailed P< 0.05 was considered statistically significant. The DL model showed predictive capability for 3-year RFS, with AUCs of 0.75 (95% CI, 0.65–0.84) in the training set, 0.74 (95% CI, 0.56–0.92) in the internal validation set, and 0.65 (95% CI, 0.53–0.78) in the external validation set. The DLR model achieved improved AUCs of 0.82 (95% CI: 0.74–0.90), 0.83 (95% CI: 0.73–0.93), and 0.67 (95% CI: 0.55–0.80) for predicting 3-year recurrence-free survival (RFS) in the training, internal validation, and external validation sets, respectively. The DLC model outperformed the DL model alone. The DLRC model achieved the best performance in the training and internal validation sets. Its predictive ability remained discernible but was attenuated in the external validation set, with AUCs of 0.95 (95% CI: 0.91–0.99), 0.89 (95% CI: 0.79–0.99), and 0.79 (95% CI: 0.67–0.91) across the respective datasets. The DLRC model effectively predicted and stratified breast cancer recurrence risk by integrating deep learning, radiomics, and clinicopathological features. 3. Stage 5.

Read PDF

Similar papers

Open access Sep 2026

MRI radiomics-based predictive modeling for risk stratification and prognostication in oral tongue carcinoma

By identifying low-risk patients within the NCCN high-risk group and high-risk patients within the NCCN low + intermediate-risk group for recurrence, these models may support treatment de-escalation and escalation, respectively, pending prospective multicenter validation.

N. Chakrabarty, S. Rane, U. Sherkhane et al. · 1 citation
Open access Sep 2026

Deep Learning-Assisted Segmentation, Multiparametric MRI Radiomics, and Clinical Features for Recurrence Risk Stratification in Young-Age Breast Cancer: A Prospective Pilot Study

MRI radiomics combined with clinical factors may provide complementary prognostic information for recurrence risk stratification in young-age breast cancer (YABC), warranting validation in larger independent cohorts.

G. Park, Jeongmin Lee, E. J. Min et al. · 0 citations
Open access Sep 2026

A radiomics–deep learning nomogram integrating intratumoral and peritumoral DCE-MRI features for pCR prediction in breast cancer

Background Pathological complete response (pCR) after neoadjuvant systemic therapy (NST) is an important surrogate endpoint for breast cancer prognosis. Reliable pretreatment prediction of pCR remains difficult, as conventional imaging underutilizes the peritumoral microenvironment, including immune infiltration, matri...

Yi-Ru Wang, Hai-Bo Wang, Jian Cui · 0 citations
Open access Sep 2026

Preoperative Prediction of Ductal Carcinoma In Situ Upstaging Using Machine Learning-Based Peritumoral Breast MRI Radiomics.

Clinical-peritumoral modeling did not significantly improve discrimination over the clinical baseline but showed higher NPV and sensitivity, suggesting the tumor microenvironment may provide complementary information for upstaging risk stratification.

K. Fernando, I. El Naqa, M. Abdalah et al. · 1 citation
Open access Sep 2026

Multichannel deep learning using multiregional DCE-MRI to predict axillary pathological complete response after neoadjuvant chemotherapy in breast cancer

To develop and compare multiregional 2D and 2.5D deep learning models based on DCE-MRI for noninvasive prediction of axillary lymph node (ALN) pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). This retrospective study enrolled 305 patients with invasive breast cancer and ipsilate...

Jun Liao, Meng-Ting Xu, Rui-Min Li et al. · 0 citations
Aug 2026

Multiparametric MRI-Based Interpretable Machine Learning Radiomics Model for Predicting Neoadjuvant Chemotherapy Sensitivity and Recurrence-Free Survival in Breast Cancer.

The interpretable radiomics-clinical model based on pretreatment mpMRI effectively predicts NAC sensitivity and RFS, offering potential to aid personalized treatment decisions.

Xin-Yi Zeng, Xian-Jun Zeng, Xiaofei Tang et al. · 0 citations

Related blog posts

Google DeepMind Blog Nov 18, 2026

Genie 4 is now available

We are rolling out a new Project Genie experience to eligible Google AI Ultra subscribers, opening access to our new Genie 4 world model.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.